462
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Clinical implications of assay specific differences in f-calprotectin when monitoring inflammatory bowel disease activity over time

, , , , &
Pages 344-350 | Received 25 Aug 2016, Accepted 31 Oct 2016, Published online: 24 Nov 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Sophie Vieujean, Romain Gillard, Pierre Delanaye, Laurence Seidel, Emeline Bequet, Catherine Salée, Marie-Alice Meuwis, Charlotte Massot, Nicolas Pierre, Paul Meunier, Etienne Cavalier & Edouard Louis. (2024) Matrix gla protein, a potential marker of tissue remodelling and physiological ageing of the gut in crohn’s disease. Scandinavian Journal of Gastroenterology 59:3, pages 296-303.
Read now
Pontus Karling, David Lundgren, Vincy Eklöf, Richard Palmqvist & Johan Hultdin. (2019) Improved monitoring of inflammatory activity in patients with ulcerative colitis by combination of faecal tests for haemoglobin and calprotectin. Scandinavian Journal of Clinical and Laboratory Investigation 79:5, pages 341-346.
Read now
Takayuki Yamamoto & Takahiro Shimoyama. (2017) Monitoring and detection of disease recurrence after resection for Crohn’s disease: the role of non-invasive fecal biomarkers. Expert Review of Gastroenterology & Hepatology 11:10, pages 899-909.
Read now

Articles from other publishers (9)

Kohei Wagatsuma, Yoshihiro Yokoyama & Hiroshi Nakase. (2021) Role of Biomarkers in the Diagnosis and Treatment of Inflammatory Bowel Disease. Life 11:12, pages 1375.
Crossref
Neeraj Narula, Emily C L Wong, Parambir S Dulai, John K Marshall, Jean-Frederic Colombel & Walter Reinisch. (2021) Week 6 Calprotectin Best Predicts Likelihood of Long-term Endoscopic Healing in Crohn’s Disease: A Post-hoc Analysis of the UNITI/IM-UNITI Trials. Journal of Crohn's and Colitis 15:3, pages 462-470.
Crossref
Gabriele Dragoni, Tommaso Innocenti & Andrea Galli. (2021) Biomarkers of Inflammation in Inflammatory Bowel Disease: How Long before Abandoning Single-Marker Approaches?. Digestive Diseases 39:3, pages 190-203.
Crossref
Małgorzata Krzystek-Korpacka, Radosław Kempiński, Mariusz Bromke & Katarzyna Neubauer. (2020) Biochemical Biomarkers of Mucosal Healing for Inflammatory Bowel Disease in Adults. Diagnostics 10:6, pages 367.
Crossref
Runqing Li, Xiuying Zhao, Jingxiao Dong, Dong Zhu, Tengjiao Wang, Song Yang, Zhipeng Zhao & Nan Xiao. (2019) Evaluation of a fluorescent immunochromatography test for fecal calprotectin. Journal of Clinical Laboratory Analysis 34:2.
Crossref
Tor Olofsson, Elisabet Lindqvist, Elisabeth Mogard, Kristofer Andréasson, Jan Marsal, Mats Geijer, Lars Erik Kristensen & Johan K Wallman. (2019) Elevated faecal calprotectin is linked to worse disease status in axial spondyloarthritis: results from the SPARTAKUS cohort. Rheumatology 58:7, pages 1176-1187.
Crossref
Shiro Nakamura, Hirotsugu Imaeda, Hiroki Nishikawa, Masaki Iimuro, Minoru Matsuura, Hideo Oka, Junsuke Oku, Takako Miyazaki, Hirohito Honda, Kenji Watanabe, Hiroshi Nakase & Akira Andoh. (2018) Usefulness of fecal calprotectin by monoclonal antibody testing in adult Japanese with inflammatory bowel diseases: a prospective multicenter study. Intestinal Research 16:4, pages 554-562.
Crossref
Catherine Reenaers, Peter Bossuyt, Pieter Hindryckx, Hilde Vanpoucke, Anneline Cremer & Filip Baert. (2018) Expert opinion for use of faecal calprotectin in diagnosis and monitoring of inflammatory bowel disease in daily clinical practice. United European Gastroenterology Journal 6:8, pages 1117-1125.
Crossref
Julie Hejl, Klaus Theede, Brian Møllgren, Kirsten Vikkelsø Madsen, Ashraf Heidari, Anna á Steig & Mogens Fenger. (2018) Point of care testing of fecal calprotectin as a substitute for routine laboratory analysis. Practical Laboratory Medicine 10, pages 10-14.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.